"Bioproperty Commercialization" 
Beyond discovery to commercial value

In order to build real commercial value around an idea or discovery, the product concept has to be supported by a complex suite of integrated activities.  Success requires not only that these activies are each managed well, but that they are coordinated along some productive pathway and each are custom fit into a unified package

Bioproperty Commercialization [AKA bioproperty development] includes:

1. Intellectual property identification, capture, and management.
2. Laboratory based development research to solve problems in analysis, process, production, or formulation.
3. Business development activities to connect to appropriate funding or marketing partners.
4. A roadmap to meaningful clinical testing or product introduction.

Have you overlooked potentially profitable, but undeveloped technology and intellectual property?

In the drive to develop 'block buster' discoveries, many biotech companies leave valuable pieces of intellectual property on the table. ABT can develop this intermediate IP into valuable licenses and products. ABT evaluates these opportunities for potential commercialization ROI versus needed development, or augmentation. Candidate IP are systematically reviewed, prioritized, refined and are then commercialized either in-house, or through partnerships or strategic alliances with appropriate companies, and academic institutions.

 ABT’s deep domain expertise enables us to maintain a strong scientific and technical focus while developing and commercializing technologies and products for a range of uses. Potential targets for development through ABT include:

• Biologics (i.e. protein and nucleic acid based therapeutics)

• Clinical diagnostic products

• Sophisticated research tools and platform technologies for biomedical R&D.

ABT’s technology focused approach allows your company to participate more broadly in the Biotechnology industry.

Contact us in full confidence for an evaluation of your potentially profitable but unused intellectual property.